OsteoRepair
Commercial- Indications
- Cancellous bone defects
Company intelligence / Profile preview
Dimensional Bioceramics has five FDA-cleared orthopedic biomaterial products for skeletal repair and two additional products in late-stage development. Their flagship offerings—OsteoRepair, OsteoRepair Hybrid, and OsteoResolve—are next-generation bioceramic cements and fillers designed to improve outcomes in fracture repair, skeletal regeneration, and treatment of infected bone sites. Clinical results are consistent with industry standards for safety and efficacy as demonstrated by 510(k) clearances.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dimensional Bioceramics.